Table 2
Intravitreal agents used prior to conversion to aflibercept
N=221 patients
Agents
Ranbizumab (average)
145
Bevacizumab (average)
76
Average injections prior to conversion
14
Interval of injections
Q6 weeks (range Q4–8 weeks)